The Management of the Societe Anonyme under the name “THRACE PLASTICS HOLDING COMPANY SOCIETE COMMERCIAL ANONYME“ and with the distinctive title “THRACE PLASTICS CO S.A.” (called as “Company” hereafter), in application of the clauses of article 17 with number 596/2014 of the Regulation of the European Parliament and the Council as of 16^th April 2014, as well as in accordance with the article 4.1.3.1 of the Regulation of the Athens Exchange, and with the aim to inform the investors' community on a timely and accurate manner, discloses the following:

From April 2020 onwards, Thrace Group implemented a number of ad-hoc investments in the production of Type I, Type II and Type IIR surgical masks in the Group's facilities in Xanthi, Greece, in Forfar, Scotland and in Clara, Ireland. The total investment cost amounted to 3 million Euro.

The investment plan was completed with great success and in a timely manner. The production lines are now in operation, with a total capacity of 1.5 million masks per day approximately. Apart from the sales generated in the Greek market, a large proportion of the production capacity is channeled to the United Kingdom and to the European Union.

The surgical masks produced are fully complied with the relevant quality standards, while the production is now performed through automated and efficient processes, thus making the overall process very competitive in financial terms, utilizing the strong technical know-how and the expertise developed.

It is noted that the investment plan included the installation of production lines for ear loops and nose wires, through which the Group has achieved a fully vertical integration of its operations. All raw materials required for surgical masks production are now produced in-house, hence strengthening the competitive advantage of the Group in this particular business activity.